| Epigenetic inactivation of microRNA gene hsa‐mir‐9‐1 in human breast cancer U Lehmann, B Hasemeier, M Christgen, M Müller, D Römermann, ... The Journal of Pathology: A Journal of the Pathological Society of Great …, 2008 | 609 | 2008 |
| Structure of the F-actin–tropomyosin complex J Von der Ecken, M Müller, W Lehman, DJ Manstein, PA Penczek, ... Nature 519 (7541), 114-117, 2015 | 415 | 2015 |
| Structure of the rigor actin-tropomyosin-myosin complex E Behrmann, M Müller, PA Penczek, HG Mannherz, DJ Manstein, ... Cell 150 (2), 327-338, 2012 | 376 | 2012 |
| MicroRNA profiles of healthy basal and luminal mammary epithelial cells are distinct and reflected in different breast cancer subtypes CL Bockmeyer, M Christgen, M Müller, S Fischer, P Ahrens, F Länger, ... Breast cancer research and treatment 130, 735-745, 2011 | 166 | 2011 |
| Low STAT3 expression sensitizes to toxic effects of β-adrenergic receptor stimulation in peripartum cardiomyopathy B Stapel, M Kohlhaas, M Ricke-Hoch, A Haghikia, S Erschow, J Knuuti, ... European heart journal 38 (5), 349-361, 2017 | 137 | 2017 |
| Distinct functional interactions between actin isoforms and nonsarcomeric myosins M Müller, RP Diensthuber, I Chizhov, P Claus, SM Heissler, M Preller, ... PloS one 8 (7), e70636, 2013 | 90 | 2013 |
| Functional characterization of the human α-cardiac actin mutations Y166C and M305L involved in hypertrophic cardiomyopathy M Müller, AJ Mazur, E Behrmann, RP Diensthuber, MB Radke, Z Qu, ... Cellular and molecular life sciences 69, 3457-3479, 2012 | 67 | 2012 |
| Epigenetic inactivation of microRNA genes in mammary carcinoma U Lehmann, B Hasemeier, D Römermann, M Müller, F Länger, H Kreipe Verhandlungen der Deutschen Gesellschaft fur Pathologie 91, 214-220, 2007 | 42 | 2007 |
| Molecular mechanisms of disease‐related human β‐actin mutations p. R183W and p. E364K N Hundt, M Preller, O Swolski, AM Ang, HG Mannherz, DJ Manstein, ... The FEBS Journal 281 (23), 5279-5291, 2014 | 37 | 2014 |
| Difference in F-Actin Depolymerization Induced by Toxin B from the Clostridium difficile Strain VPI 10463 and Toxin B from the Variant Clostridium difficile Serotype … M May, T Wang, M Müller, H Genth Toxins 5 (1), 106-119, 2013 | 35 | 2013 |
| Serelaxin treatment promotes adaptive hypertrophy but does not prevent heart failure in experimental peripartum cardiomyopathy J Nonhoff, M Ricke-Hoch, M Mueller, B Stapel, T Pfeffer, M Kasten, ... Cardiovascular Research 113 (6), 598-608, 2017 | 34 | 2017 |
| The combined repetitive oligopeptides of Clostridium difficile toxin A counteract premature cleavage of the glucosyl-transferase domain by stabilizing protein conformation A Olling, C Hüls, S Goy, M Müller, S Krooss, I Rudolf, H Tatge, R Gerhard Toxins 6 (7), 2162-2176, 2014 | 32 | 2014 |
| Phalloidin perturbs the interaction of human non-muscle myosin isoforms 2A and 2C1 with F-actin RP Diensthuber, M Müller, SM Heissler, MH Taft, I Chizhov, DJ Manstein Febs Letters 585 (5), 767-771, 2011 | 20 | 2011 |
| Annual Bleeding Rates: Pitfalls of Clinical Trial Outcomes in Hemophilia Patients C Keipert, M Müller‐Olling, F Gauly, C Arras‐Reiter, A Hilger Clinical and Translational Science, 2020 | 11 | 2020 |
| Heterogeneity in COVID‐19 convalescent plasma clinical trials M Müller‐Olling, U Vahlensieck, A Hilger Clinical pharmacology and therapeutics 111 (5), 995, 2022 | 8 | 2022 |
| Epidemiological challenges in rare bleeding disorders: Fviii inhibitor incidence in haemophilia a patients—a known issue of unknown origin C Keipert, U Drechsel-Bäuerle, D Oberle, M Müller-Olling, A Hilger International Journal of Environmental Research and Public Health 18 (1), 225, 2021 | 7 | 2021 |
| Experimental study of aerosol reentrainment from flashing pool during controlled filtered venting of the containment after a severe core melt accident M Müller, R von Rohr Journal of Aerosol Science 26, S701-S702, 1995 | 1 | 1995 |
| Deep vein thrombosis and pulmonary embolism: a prospective, observational study to evaluate diagnostic performance of the Tina-quant D-Dimer Gen. 2 assay T Bertsch, W Behringer, S Blaschke, R Body, S Davidson, M Müller-Olling, ... Frontiers in Cardiovascular Medicine 10, 2023 | | 2023 |
| Clinical efficacy of different treatment options for haemophilia: Pitfalls of comparing annual bleeding rates C Keipert, M Mueller-Olling, F Gauly, C Arras-Reiter, A Hilger HAEMOPHILIA 25, 68-68, 2019 | | 2019 |
| Our muscle at near‐atomic resolution‐Cryo‐EM structure of the F‐actin‐tropomyosin complex J von der Ecken, M Müller, W Lehman, DJ Manstein, PA Penczek, ... European Microscopy Congress 2016: Proceedings, 7-8, 2016 | | 2016 |
Dietmar J. MansteinBiophysical Chemistry at MHHBestätigte E-Mail-Adresse bei mh-hannover.de
